09:01 AM EDT, 03/27/2024 (MT Newswires) -- Health care stocks were higher pre-bell Wednesday as the Health Care Select Sector SPDR Fund (XLV) was up 0.6% and the iShares Biotechnology ETF (IBB) was recently advancing by 0.8%.

NovoCure ( NVCR ) was up nearly 17% after saying its Tumor Treating Fields therapy for brain metastases from non-small cell lung cancer met the primary endpoint in a phase 3 trial.